Elizabeth M. Billingsley, MD, FAAD
SESSIONS
No sessions scheduled for this speaker.
DISCLOSURES
Inhibitor Therapeutics – Consultant (1099 relationship)(Fees); PellePharm, Inc. – Investigator(Grants/Research Funding); Regeneron – Investigator(Grants/Research Funding); Sol Gel Technologies – Investigator(Grants/Research Funding);